NON CONTROLLING INTEREST (Details) - USD ($) |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
Net loss attributable to the non-controlling interest | $ (934) | $ (551) |
BioCorRx Pharmaceuticals, Inc [Member] | ||
Net loss | $ (1,447) | $ (2,276) |
Average Non-controlling interest percentage of profit/losses | 24.20% | 24.20% |
Net loss attributable to the non-controlling interest | $ (350) | $ 551 |
Joseph DeSanto MD [Member] | ||
Net loss | $ (1,668) | |
Average Non-controlling interest percentage of profit/losses | 35.00% | |
Net loss attributable to the non-controlling interest | $ (584) |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|